Named Executive Officers — FY2025
Compensation Analysis
Computed directly from SEC-sourced figures tracked on this page — not a general description.
Biogen Inc.'s available SEC proxy filings disclose compensation for a single named executive officer: Robin Kramer (Chief Financial Officer).
Cash compensation (salary plus bonus) made up 13% of Biogen Inc.'s FY2025 tracked executive pay, with stock awards accounting for 0%.
Among 78 other Healthcare companies in this dataset, Biogen Inc.'s combined tracked executive pay of $5.8M ranks in the 26th percentile (industry median: $13.6M). Its highest-paid executive, Robin Kramer, ranks in the 49th percentile for top-executive pay in the sector (industry median: $6.3M).
Compensation figures on this page for Biogen Inc. come directly from its SEC DEF 14A proxy statement(s), filed with the SEC via EDGAR — not from crowdsourced or self-reported salary data.